missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
R&D Systems™ Recombinant Human VEGF 165 Protein
Klicka för att se tillgängliga alternativ
Kvantitet:
1 mg
10 μg
50 μg
500 μg
Formulering:
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose.
Beskrivning
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 1-6 ng/mL. The specific activity of recombinant human VEGF165 is approximately 1.7 x 103 U/μg, which is calibrated against recombinant human VEGF165 WHO Standard (NIBSC code: 02/286). Specific activity is for reference purposes only and is not routinely tested.
Specifikationer
Specifikationer
| Formulering | Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Gen-ID (Entrez) | 7422 |
| Molekylvikt (g/mol) | observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions. |
| Namn | VEGF 165 |
| Kvantitet | 50 μg |
| Källa | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191 |
| Förvaringskrav | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Strukturell form | Disulfide-linked homodimer |
| Konjugera | Unconjugated |
| Rekombinant | Recombinant |
| Visa mer |
Korrigering av produktinnehåll
Din input är viktig för oss. Fyll i det här formuläret för att ge feedback relaterad till innehållet på denna produkt.
Produkttitel
Hittar du en möjlighet till förbättring?Dela en innehållskorrigering